↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Malmberg K) "

Search: WFRF:(Malmberg K)

Result 11-20 of 262

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
11.	Bartnik, M, et al. (author) Abnormal glucose regulation in patients with coronary artery disease across Europe 2004 In: DIABETOLOGIA. - 0012-186X. ; 47, s. A61-A61 Conference paper (other academic/artistic)
12.	Bartnik, M, et al. (author) Recognising abnormal glucose regulation in patients with coronary artery disease 2005 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 26, s. 324-324 Conference paper (other academic/artistic)
13.	Bartnik, M, et al. (author) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart 2004 In: European heart journal. - : Oxford University Press (OUP). - 0195-668X. ; 25:21, s. 1880-1890 Journal article (peer-reviewed)
14.	Choudhury, A, et al. (author) First International Meeting of the Thematic Centre for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC) 13-14 June 2011, Ljusterö, Sweden 2012 In: Cancer immunology, immunotherapy : CII. - : Springer Science and Business Media LLC. - 1432-0851 .- 0340-7004. ; 61:4, s. 587-91 Journal article (other academic/artistic)
15.	DELLBORG, M, et al. (author) Dynamic on-line vectorcardiography improves and simplifies in-hospital ischemia monitoring of patients with unstable angina 1995 In: Journal of the American College of Cardiology. - : Elsevier BV. - 0735-1097. ; 26:6, s. 1501-1507 Journal article (peer-reviewed)
16.	Gustafsson, I, et al. (author) NT-proBNP is a potent prognostic marker in patients with type 2 diabetes hospitalized for acute coronary syndrome - a DIGAMI 2 sub study 2010 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 31, s. 514-515 Conference paper (other academic/artistic)
17.	Hammer, Q., et al. (author) Genetic ablation of adhesion ligands effectively averts rejection of allogeneic immune cells 2022 In: European Journal of Immunology. - : WILEY. - 0014-2980 .- 1521-4141. ; 52, s. 23-23 Journal article (other academic/artistic)
18.	Lindahl, B, et al. (author) Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group 1997 In: European heart journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 18:5, s. 762-770 Journal article (peer-reviewed)
19.	Lindman, Henrik, et al. (author) A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1) 2018 In: European Journal of Cancer. - : Elsevier BV. - 0959-8049 .- 1879-0852. ; 94, s. 79-86 Journal article (peer-reviewed)abstract Study aim: Retrospective studies have demonstrated a worse outcome in breast cancer patients not developing leukopenia during adjuvant chemotherapy. The SBG 2000-1 is the first randomised trial designed to compare individually dosed chemotherapy without G-CSF support based on grade of toxicity to standard-dosed chemotherapy based on body surface area (BSA). Methods: Patients with early breast cancer were included and received the first cycle of standard FEC (fluorouracil 600 mg/m2, epirubicin 60 mg/m2, cyclophosphamide 600 mg/m2). Patients with nadir leukopenia grade 0–2 after first cycle were randomised between either 6 additional courses of tailored FEC with increased doses (E 75–90 mg/m2, C 900–1200 mg/m2) or fixed treatment with 6 standard FEC. Patients with grade 3–4 leukopenia were registered and treated with 6 standard FEC. Primary end-point was distant disease-free survival (DDFS). Results: The study enrolled 1535 patients, of which 1052 patients were randomised to tailored FEC (N = 524) or standard FEC (N = 528), whereas 401 patients with leukopenia grade 3–4 continued standard FEC and formed the registered cohort. Dose escalation did not statistically significantly improve 10-year DDFS (79% and 77%, HR 0.87, CI 0.67–1.14, P = 0.32) or OS (82% and 78%, respectively, HR 0.89, CI 0.57–1.16, P = 0.38). Corresponding estimates for the registered group of patients were DDFS 79% and OS 82%, respectively. Conclusions: The SBG 2000-1 study failed to show a statistically significant improvement of escalated and tailored-dosed chemotherapy compared with standard BSA-based chemotherapy in patients with low haematological toxicity, although all efficacy parameters showed a numerical advantage for tailored treatment.
20.	Malmberg, KJ, et al. (author) IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism 2002 In: The Journal of clinical investigation. - 0021-9738. ; 110:10, s. 1515-1523 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 11-20 of 262

Refine your search

Type of publication: journal article (190); conference paper (56); research review (5); book chapter (3); reports (2); other publication (2); show more...; doctoral thesis (2); review (2); show less...

Type of content: peer-reviewed (179); other academic/artistic (83)

Author/Editor: Malmberg, K (129); Rydén, L. (101); Norhammar, A. (37); Malmberg, KJ (33); Andersson, Eva K (20); Malmberg, Bo (19); show more...; Ohrvik, J (17); Ljunggren, HG (16); Malmberg, P (15); Larsson, K (14); Palmberg, L (10); Hamsten, A (10); Waldenstrom, A. (7); Malmberg, Bo, 1958- (7); Sandberg, JK (6); Herlitz, J (6); Efendic, S (6); Herlitz, Johan (6); Kiessling, R (6); Schaffer, M (6); Hansen, A. (5); Béziat, V (5); Lee, T. (5); Dickstein, K (5); Bjorkstrom, NK (5); Lincoff, AM (5); Cichocki, F (5); Miller, JS (5); Wimark, Thomas, 1979 ... (5); Eriksson, LI (4); Nilsson, G (4); Jonsson, B (4); Martensson, A (4); Buggert, M (4); Wallentin, L (4); Andersson, Eva K., 1 ... (4); Svensson, A (4); Malmberg, Per, 1974 (4); Rooyackers, O (4); Aleman, S (4); Bjorklund, A (4); Lahti, J (4); Snieder, H. (4); Näsman, Per (4); Schedvins, K (4); Laakso, M. (4); Simoons, ML (4); Sigurdsson, G (4); Malmberg, Filip (4); Johansson, Boo (4); show less...

University: Karolinska Institutet (191); Stockholm University (24); University of Gothenburg (23); Uppsala University (23); Umeå University (12); Royal Institute of Technology (10); show more...; Lund University (9); Linköping University (7); University of Borås (7); Jönköping University (6); Chalmers University of Technology (6); RISE (2); Swedish University of Agricultural Sciences (2); Luleå University of Technology (1); Örebro University (1); Malmö University (1); Stockholm School of Economics (1); Södertörn University (1); show less...

Language: English (259); Swedish (3)

Research subject (UKÄ/SCB): Medical and Health Sciences (46); Social Sciences (30); Natural sciences (9); Engineering and Technology (5)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view